KENNEDY CAPITAL MANAGEMENT LLC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 884589
ST LOUIS, MO
Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$29,702,046
+$1,467,835 QoQ
Shares Held
1,199,598
-0.8% QoQ
Ownership
0.980%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $354,986,312 across 62 Biotechnology names. CPRX ranks #2 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
484,580 | $31,318,405 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
1,199,598 | $29,702,046 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
137,099 | $14,450,234 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
360,490 | $13,875,260 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
408,492 | $13,075,828 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
304,615 | $12,279,030 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
352,302 | $11,175,019 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
122,669 | $10,325,049 |
All Filings in CPRX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,702,046 | 1,199,598 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $28,234,211 | 1,209,692 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,886,077 | 1,060,207 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,905,303 | 1,009,461 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,737,082 | 1,061,323 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $21,238,689 | 1,017,666 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,703,350 | 1,041,416 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,769,948 | 1,276,304 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,923,561 | 1,061,704 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,874,032 | 527,902 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,439,118 | 636,366 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,069,685 | 302,804 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||